GREGORY FOSTER: Open Payments
NPI 1003076704 · EL CAMPO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 19 payments from 10 companies in 2025. Trend: 2023 $270 · 2024 $408 · 2025 $462
Food & beverage: $377Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| Amgen Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $42 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $34 |
| UCB, Inc. | 1 | $32 |
| Organon LLC | 4 | $23 |
| Galderma Laboratories, L.P. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| LEO Pharma Inc. | 1 | $15 |
Products named: OTEZLA, TREMFYA, Cabtreo, Bimzelx, NEMLUVIO, Sotyktu, ANZUPGO, VTAMA.
Industry payments across TX — which companies pay providers there.
